Georgina El Hajjar

机构：The University of Texas MD Anderson Cancer Center · ORCID：0009-0004-5596-5966

发表论文 18 篇 · 总被引 25 次 · h-index 3

代表论文

• Phase II Study of the all-oral combination of revumenib (SNDX-5613) with decitabine/cedazuridine (ASTX727) and venetoclax (SAVE) in newly diagnosed AML (2025 · Blood · 被引 13)
• Effect of 24-hour preservation with oxygen free radical scavengers on isolated-perfused canine heart-lungs. (1986 · PubMed · 被引 8)
• Immunophenotypic changes following menin inhibition in acute myeloid leukemia (2026 · Leukemia · 被引 3)
• Post-transplant maintenance with revumenib in children with HOX-driven AML (2025 · Blood · 被引 2)
• Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia (2026 · Cancer)
• Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE) (2026 · Journal of Clinical Oncology)